Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes
- PMID: 241614
Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes
Abstract
Norethisterone, specifically labeled with tritium, was incubated with hepatic microsomes of rats. About 2% of 3H radioactivity was irreversibly incorporated into the microsomal protein. This protein binding of norethisterone (about 0.7-1.6 nmol/mg of microsomal protein) was dependent on oxygen, NADPH, substrate concentration, and microsomal protein content and could be inhibited by carbon monoxide. Glutathione and other cysteine derivatives with free sulfhydryl groups diminished the microsomal protein binding diminished the microsomal protein binding as did the addition of bovine serum albumin. Norethisterone-derived radioactivity was also irreversibly bound to albumin. Solvent-extraction and charcoal-adsorption methods were employed to prove the irreversible nature of this binding. After trypsin digestion of albumin and microsomal protein loaded with norethisterone, peptides which were labeled with 3H could be isolated. To explain our results, a metabolic bioactivation of norethisterone to norethisterone-4,5-epoxide, catalyzed by the microsomal mixed-function oxidase cytochrome P-450, is proposed.
Similar articles
-
Irreversible protein binding of norethisterone (norethindrone) epoxide.Steroids. 1976 Jan;27(1):29-45. doi: 10.1016/0039-128x(76)90067-2. Steroids. 1976. PMID: 4905
-
Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.Drug Metab Dispos. 1986 Jul-Aug;14(4):386-91. Drug Metab Dispos. 1986. PMID: 2873983
-
Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.J Pharmacol Exp Ther. 1981 Oct;219(1):207-12. J Pharmacol Exp Ther. 1981. PMID: 6793710
-
Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.Cancer Res. 1984 Oct;44(10):4615-21. Cancer Res. 1984. PMID: 6380709
-
Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.Drug Metab Dispos. 1993 Sep-Oct;21(5):874-82. Drug Metab Dispos. 1993. PMID: 7902251
Cited by
-
Self-catalyzed destruction of cytochrome P-450: covalent binding of ethynyl sterols to prosthetic heme.Proc Natl Acad Sci U S A. 1979 Feb;76(2):746-9. doi: 10.1073/pnas.76.2.746. Proc Natl Acad Sci U S A. 1979. PMID: 284396 Free PMC article.
-
Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.Biochem J. 1977 Jul 15;166(1):57-64. doi: 10.1042/bj1660057. Biochem J. 1977. PMID: 901418 Free PMC article.
-
Structural modifications in contraceptive steroids altering their metabolism and toxicity.Arch Toxicol. 1977 Dec 30;39(1-2):13-9. doi: 10.1007/BF00343271. Arch Toxicol. 1977. PMID: 579976
-
Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem.Biochem J. 1978 Sep 15;174(3):853-61. doi: 10.1042/bj1740853. Biochem J. 1978. PMID: 728091 Free PMC article.
-
The significance of covalent binding of catechols to proteins in vivo.Arch Toxicol. 1977 Dec 30;39(1-2):31-9. doi: 10.1007/BF00343273. Arch Toxicol. 1977. PMID: 579980